Agenus (AGEN) EBT Margin (2010 - 2026)

Agenus (AGEN) posted quarterly EBT Margin of 1.08% for Q1 2026, up 11034.0% year-over-year from N/an in Q1 2025, and up 122.35% quarter-over-quarter from 4.83% in Q4 2025.

Agenus (AGEN) EBT Margin (2010 - 2026) Analysis & Trends

Agenus' EBT Margin history runs 17 years deep, the most recent figure standing at 1.08% for Q1 2026.

  • In Q1 2026, EBT Margin rose 11034.0% year-over-year to 1.08%; the TTM figure through Mar 2026 stood at 30.93% (up 17408.0% YoY), while the FY2025 annual figure was 363.48%, up 13831.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 1.08%, up from 4.83% in the prior quarter.
  • The five-year high for EBT Margin was 130.93% in Q4 2022, with the low at 271.79% in Q3 2024.
  • The 5-year median for EBT Margin is 175.17% (2024), against an average of 139.99%.
  • The sharpest annual moves came in 2022 and 2023: EBT Margin jumped 99642 bps in 2022, then tumbled 25686 bps in 2023.
  • Agenus' EBT Margin stood at 130.93% in 2022, then slumped by 196 bps to 125.93% in 2023, then slumped by 39 bps to 175.17% in 2024, then surged by 97 bps to 4.83% in 2025, then surged by 122 bps to 1.08% in 2026.
  • Business Quant data shows AGEN's EBT Margin at 1.08% in Q1 2026, 4.83% in Q4 2025, and 23.06% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 35.61%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 34.77%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 18.33%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -94.22%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 13.77%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -2.67%
10 Agenus 311.95 Mn 286.43 Mn 34.52 Mn -11.79%

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.79%
Mar 31, 2026 1.08%
Dec 31, 2025 -4.83%
Sep 30, 2025 -23.06%
Jun 30, 2025 -116.98%
Mar 31, 2025 -109.26%
Dec 31, 2024 -175.17%
Sep 30, 2024 -271.79%
Jun 30, 2024 -265.76%
Mar 31, 2024 -225.52%
Dec 31, 2023 -125.93%
Sep 30, 2023 -192.24%
Jun 30, 2023 -217.69%
Mar 31, 2023 -240.90%
Dec 31, 2022 130.93%
Sep 30, 2022 -185.51%
Jun 30, 2022 -215.83%
Mar 31, 2022 -141.32%
Dec 31, 2021 -272.77%
Sep 30, 2021 52.66%